[uupretirees] AstraZeneca scraps a lineup of drugs in pipeline cleanup; Takeda, 5AM back a Fred Hutch spinoff with grand ambitions

  • From: hils. <dmarc-noreply@xxxxxxxxxxxxx> (Redacted sender "bkasprak" for DMARC)
  • To: "uupretirees@xxxxxxxxxxxxx" <uupretirees@xxxxxxxxxxxxx>
  • Date: Thu, 11 Feb 2021 13:09:01 +0000 (UTC)

FyiBob Kasprak======================================


-----Original Message-----
From: Amber and Arsalan — Endpoints News <earlyedition@xxxxxxxxxxxxxxxxx>
To: bob kasprak <bkasprak@xxxxxxx>
Sent: Thu, Feb 11, 2021 7:54 am
Subject: AstraZeneca scraps a lineup of drugs in pipeline cleanup; Takeda, 5AM 
back a Fred Hutch spinoff with grand ambitions

 @media only screen and (min-width:620px){#yiv9121800381 
.yiv9121800381wrapper{min-width:600px !important;}#yiv9121800381 
.yiv9121800381wrapper h1{}#yiv9121800381 .yiv9121800381wrapper 
h1{font-size:34px !important;line-height:43px !important;}#yiv9121800381 
.yiv9121800381wrapper h2{}#yiv9121800381 .yiv9121800381wrapper 
h2{font-size:26px !important;line-height:34px !important;}#yiv9121800381 
.yiv9121800381wrapper h3{}#yiv9121800381 .yiv9121800381wrapper 
h3{font-size:24px !important;line-height:32px !important;}#yiv9121800381 
.yiv9121800381column{}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-8{font-size:8px !important;line-height:14px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-9{font-size:9px !important;line-height:16px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-10{font-size:10px !important;line-height:18px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-11{font-size:11px !important;line-height:19px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-12{font-size:12px !important;line-height:19px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-13{font-size:13px !important;line-height:21px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-14{font-size:14px !important;line-height:21px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-15{font-size:15px !important;line-height:23px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-16{font-size:16px !important;line-height:24px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-17{font-size:17px !important;line-height:26px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-18{font-size:18px !important;line-height:26px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-20{font-size:20px !important;line-height:28px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-22{font-size:22px !important;line-height:31px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-24{font-size:24px !important;line-height:32px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-26{font-size:26px !important;line-height:34px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-28{font-size:28px !important;line-height:36px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-30{font-size:30px !important;line-height:38px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-32{font-size:32px !important;line-height:40px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-34{font-size:34px !important;line-height:43px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-36{font-size:36px !important;line-height:43px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-40{font-size:40px !important;line-height:47px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-44{font-size:44px !important;line-height:50px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-48{font-size:48px !important;line-height:54px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-56{font-size:56px !important;line-height:60px 
!important;}#yiv9121800381 .yiv9121800381wrapper 
.yiv9121800381size-64{font-size:64px !important;line-height:63px 
!important;}}#yiv9121800381 body {margin:0;padding:0;}#yiv9121800381 table 
{border-collapse:collapse;table-layout:fixed;}#yiv9121800381 * 
{line-height:inherit;}#yiv9121800381 .filtered99999 {color:inherit 
!important;text-decoration:none !important;}#yiv9121800381 
.yiv9121800381wrapper .yiv9121800381footer__share-button a:hover, 
#yiv9121800381 .yiv9121800381wrapper .yiv9121800381footer__share-button a:focus 
{color:#ffffff !important;}#yiv9121800381 .yiv9121800381btn a:hover, 
#yiv9121800381 .yiv9121800381btn a:focus, #yiv9121800381 
.yiv9121800381footer__share-button a:hover, #yiv9121800381 
.yiv9121800381footer__share-button a:focus, #yiv9121800381 
.yiv9121800381email-footer__links a:hover, #yiv9121800381 
.yiv9121800381email-footer__links a:focus {}#yiv9121800381 
.yiv9121800381preheader, #yiv9121800381 .yiv9121800381header, #yiv9121800381 
.yiv9121800381layout, #yiv9121800381 .yiv9121800381column {transition:width 
0.25s ease-in-out, 0.25s ease-in-out;}#yiv9121800381 .yiv9121800381preheader td 
{padding-bottom:8px;}#yiv9121800381 .yiv9121800381layout, #yiv9121800381 
div.yiv9121800381header {max-width:400px !important;}#yiv9121800381 
div.yiv9121800381preheader {max-width:360px !important;}#yiv9121800381 
.yiv9121800381snippet, #yiv9121800381 .yiv9121800381webversion {Float:none 
!important;}#yiv9121800381 .yiv9121800381stack .yiv9121800381column 
{max-width:400px !important;width:100% !important;}#yiv9121800381 
.yiv9121800381fixed-width.yiv9121800381has-border {max-width:402px 
!important;}#yiv9121800381 .yiv9121800381fixed-width.yiv9121800381has-border 
.yiv9121800381layout__inner {}#yiv9121800381 .yiv9121800381snippet, 
#yiv9121800381 .yiv9121800381webversion {width:50% !important;}#yiv9121800381 
.yiv9121800381ie .yiv9121800381btn {width:100%;}#yiv9121800381 .yiv9121800381ie 
.yiv9121800381stack .yiv9121800381column, #yiv9121800381 .yiv9121800381ie 
.yiv9121800381stack .yiv9121800381gutter {display:table-cell;float:none 
!important;}#yiv9121800381 .yiv9121800381ie div.yiv9121800381preheader, 
#yiv9121800381 .yiv9121800381ie .yiv9121800381email-footer {max-width:560px 
!important;width:560px !important;}#yiv9121800381 .yiv9121800381ie 
.yiv9121800381snippet, #yiv9121800381 .yiv9121800381ie .yiv9121800381webversion 
{width:280px !important;}#yiv9121800381 .yiv9121800381ie 
div.yiv9121800381header, #yiv9121800381 .yiv9121800381ie .yiv9121800381layout 
{max-width:600px !important;width:600px !important;}#yiv9121800381 
.yiv9121800381ie .yiv9121800381two-col .yiv9121800381column {max-width:300px 
!important;width:300px !important;}#yiv9121800381 .yiv9121800381ie 
.yiv9121800381three-col .yiv9121800381column, #yiv9121800381 .yiv9121800381ie 
.yiv9121800381narrow {max-width:200px !important;width:200px 
!important;}#yiv9121800381 .yiv9121800381ie .yiv9121800381wide {width:400px 
!important;}#yiv9121800381 .yiv9121800381ie 
.yiv9121800381stack.yiv9121800381fixed-width.yiv9121800381has-border, 
#yiv9121800381 .yiv9121800381ie 
.yiv9121800381stack.yiv9121800381has-gutter.yiv9121800381has-border 
{max-width:602px !important;width:602px !important;}#yiv9121800381 
.yiv9121800381ie 
.yiv9121800381stack.yiv9121800381two-col.yiv9121800381has-gutter 
.yiv9121800381column {max-width:290px !important;width:290px 
!important;}#yiv9121800381 .yiv9121800381ie 
.yiv9121800381stack.yiv9121800381three-col.yiv9121800381has-gutter 
.yiv9121800381column, #yiv9121800381 .yiv9121800381ie 
.yiv9121800381stack.yiv9121800381has-gutter .yiv9121800381narrow 
{max-width:188px !important;width:188px !important;}#yiv9121800381 
.yiv9121800381ie .yiv9121800381stack.yiv9121800381has-gutter .yiv9121800381wide 
{max-width:394px !important;width:394px !important;}#yiv9121800381 
.yiv9121800381ie 
.yiv9121800381stack.yiv9121800381two-col.yiv9121800381has-gutter.yiv9121800381has-border
 .yiv9121800381column {max-width:292px !important;width:292px 
!important;}#yiv9121800381 .yiv9121800381ie 
.yiv9121800381stack.yiv9121800381three-col.yiv9121800381has-gutter.yiv9121800381has-border
 .yiv9121800381column, #yiv9121800381 .yiv9121800381ie 
.yiv9121800381stack.yiv9121800381has-gutter.yiv9121800381has-border 
.yiv9121800381narrow {max-width:190px !important;width:190px 
!important;}#yiv9121800381 .yiv9121800381ie 
.yiv9121800381stack.yiv9121800381has-gutter.yiv9121800381has-border 
.yiv9121800381wide {max-width:396px !important;width:396px 
!important;}#yiv9121800381 .yiv9121800381ie .yiv9121800381fixed-width 
.yiv9121800381layout__inner {border-left:0 none white !important;border-right:0 
none white !important;}#yiv9121800381 .yiv9121800381ie 
.yiv9121800381layout__edges {display:none;}#yiv9121800381 .yiv9121800381mso 
.yiv9121800381layout__edges {font-size:0;}#yiv9121800381 
.yiv9121800381layout-fixed-width, #yiv9121800381 .yiv9121800381mso 
.yiv9121800381layout-full-width {background-color:#ffffff;}@media only screen 
and (min-width:620px) {#yiv9121800381 .yiv9121800381column, #yiv9121800381 
.yiv9121800381gutter {display:table-cell;Float:none 
!important;vertical-align:top;}#yiv9121800381 div.yiv9121800381preheader, 
#yiv9121800381 .yiv9121800381email-footer {max-width:560px 
!important;width:560px !important;}#yiv9121800381 .yiv9121800381snippet, 
#yiv9121800381 .yiv9121800381webversion {width:280px !important;}#yiv9121800381 
div.yiv9121800381header, #yiv9121800381 .yiv9121800381layout, #yiv9121800381 
.yiv9121800381one-col .yiv9121800381column {max-width:600px 
!important;width:600px !important;}#yiv9121800381 
.yiv9121800381fixed-width.yiv9121800381has-border, #yiv9121800381 
.yiv9121800381fixed-width.yiv9121800381x_has-border, #yiv9121800381 
.yiv9121800381has-gutter.yiv9121800381has-border, #yiv9121800381 
.yiv9121800381has-gutter.yiv9121800381x_has-border {max-width:602px 
!important;width:602px !important;}#yiv9121800381 .yiv9121800381two-col 
.yiv9121800381column {max-width:300px !important;width:300px 
!important;}#yiv9121800381 .yiv9121800381three-col .yiv9121800381column, 
#yiv9121800381 .yiv9121800381column.yiv9121800381narrow, #yiv9121800381 
.yiv9121800381column.yiv9121800381x_narrow {max-width:200px 
!important;width:200px !important;}#yiv9121800381 
.yiv9121800381column.yiv9121800381wide, #yiv9121800381 
.yiv9121800381column.yiv9121800381x_wide {width:400px 
!important;}#yiv9121800381 .yiv9121800381two-col.yiv9121800381has-gutter 
.yiv9121800381column, #yiv9121800381 
.yiv9121800381two-col.yiv9121800381x_has-gutter .yiv9121800381column 
{max-width:290px !important;width:290px !important;}#yiv9121800381 
.yiv9121800381three-col.yiv9121800381has-gutter .yiv9121800381column, 
#yiv9121800381 .yiv9121800381three-col.yiv9121800381x_has-gutter 
.yiv9121800381column, #yiv9121800381 .yiv9121800381has-gutter 
.yiv9121800381narrow {max-width:188px !important;width:188px 
!important;}#yiv9121800381 .yiv9121800381has-gutter .yiv9121800381wide 
{max-width:394px !important;width:394px !important;}#yiv9121800381 
.yiv9121800381two-col.yiv9121800381has-gutter.yiv9121800381has-border 
.yiv9121800381column, #yiv9121800381 
.yiv9121800381two-col.yiv9121800381x_has-gutter.yiv9121800381x_has-border 
.yiv9121800381column {max-width:292px !important;width:292px 
!important;}#yiv9121800381 
.yiv9121800381three-col.yiv9121800381has-gutter.yiv9121800381has-border 
.yiv9121800381column, #yiv9121800381 
.yiv9121800381three-col.yiv9121800381x_has-gutter.yiv9121800381x_has-border 
.yiv9121800381column, #yiv9121800381 
.yiv9121800381has-gutter.yiv9121800381has-border .yiv9121800381narrow, 
#yiv9121800381 .yiv9121800381has-gutter.yiv9121800381x_has-border 
.yiv9121800381narrow {max-width:190px !important;width:190px 
!important;}#yiv9121800381 .yiv9121800381has-gutter.yiv9121800381has-border 
.yiv9121800381wide, #yiv9121800381 
.yiv9121800381has-gutter.yiv9121800381x_has-border .yiv9121800381wide 
{max-width:396px !important;width:396px !important;}}@supports (display:flex) 
{@media only screen and (min-width:620px) {#yiv9121800381 
.yiv9121800381fixed-width.yiv9121800381has-border .yiv9121800381layout__inner 
{display:flex !important;}}}@media only screen and ( _filtered_a ) _filtered 
;#yiv9121800381 body{background-color:#e6e6e6;}#yiv9121800381 
.yiv9121800381logo a:hover, #yiv9121800381 .yiv9121800381logo 
a:focus{color:#859bb1 !important;}#yiv9121800381 .yiv9121800381mso 
.yiv9121800381layout-has-border{border-top:1px solid #b3b3b3;border-bottom:1px 
solid #b3b3b3;}#yiv9121800381 .yiv9121800381mso 
.yiv9121800381layout-has-bottom-border{border-bottom:1px solid 
#b3b3b3;}#yiv9121800381 .yiv9121800381mso .yiv9121800381border, #yiv9121800381 
.yiv9121800381ie .yiv9121800381border{background-color:#b3b3b3;}#yiv9121800381 
.yiv9121800381mso h1, #yiv9121800381 .yiv9121800381ie h1{}#yiv9121800381 
.yiv9121800381mso h1, #yiv9121800381 .yiv9121800381ie h1{font-size:34px 
!important;line-height:43px !important;}#yiv9121800381 .yiv9121800381mso h2, 
#yiv9121800381 .yiv9121800381ie h2{}#yiv9121800381 .yiv9121800381mso h2, 
#yiv9121800381 .yiv9121800381ie h2{font-size:26px !important;line-height:34px 
!important;}#yiv9121800381 .yiv9121800381mso h3, #yiv9121800381 
.yiv9121800381ie h3{}#yiv9121800381 .yiv9121800381mso h3, #yiv9121800381 
.yiv9121800381ie h3{font-size:24px !important;line-height:32px 
!important;}#yiv9121800381 .yiv9121800381mso .yiv9121800381layout__inner, 
#yiv9121800381 .yiv9121800381ie .yiv9121800381layout__inner{}#yiv9121800381 
.yiv9121800381mso .yiv9121800381footer__share-button p{}#yiv9121800381 
.yiv9121800381mso .yiv9121800381footer__share-button p{font-family:Lato, 
Tahoma, sans-serif;}Novo Nordisk's semaglutide blows the doors off in obesity ‌ 
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
|        No images? Click here                            
M  T  W  Th  F
 February 11, 2021
                  Next Generation Metabolomics: Transforming Early Discovery 
into Clinical Development →                Is Australia the next Global 
Destination for Phase 2? →                                 PREMIUM     SR One 
recruits an IPO vet and seasoned ops chief for the venture team. And they have 
some practical advice for you 🔐
Endpoints News                                          NEWS     Novo Nordisk's 
blockbuster diabetes drug blows the doors off in obesity, proving highly 
effective in driving weight loss →
Endpoints News
 As US data for Covid-19 vaccine loom, AstraZeneca cleans house and scraps 
several asthma, cancer drugs from pipeline →
Endpoints News
 Sana gets a competitor as Takeda, 5AM pour $70M into a Fred Hutch pioneer's 
quest to unseat CAR-T, ex-vivo gene therapy →
Endpoints News
 After purging its own candidates, Merck says it's ready to assist in Covid-19 
vaccine production →
Endpoints News
 AstraZeneca looks to rebound from production delays for its Covid-19 vaccine 
with new fill-finish deal →
Endpoints News
 A lone infection may have changed the course of the pandemic →
WIRED
 The Vaccine Had to Be Used. He Used It. He Was Fired. →
NY Times                                           EDITOR'S NOTE     Who are 
the young biopharma leaders shaping the industry? Nominate them for Endpoints' 
special report →
Endpoints News                             Launched in 2020, these new events 
unite hundreds of early-stage biotechs, renowned pharma and more to accelerate 
immunology pipelines. High-quality partnering focused ONLY on immunology. →     
                              
   - Cellular/molecular immunologist w/ CRISPR gene editing skills (PhD)   
EvolveImmune Therapeutics   
Branford, CT
          
   - Senior Research Associate, Cell Biology and Drug Discovery   
Hexagon BioMenlo Park, CA
              
   - Senior Scientist I, Vector Analytics - Gene Therapy Research   
BioMarin Pharmaceutical   
San Rafael, CA
          
   - Associate Director, RNA BiologyArrakis Therapeutics   
Waltham, MA
              
   - Scientist 1 or 2, AAV Purification - Gene Therapy Research   
BioMarin Pharmaceutical   
San Rafael, CA
          
   - Scientist II, Genetics Research and Delivery   
BioMarin Pharmaceutical   
San Rafael, CA
           Browse Careers     Recruit talent with Endpoints Careers →
Contact Melissa Nazzaro: melissa@xxxxxxxxxxxxxxxxx                        
February 16, 2 PM EST
Leveraging APAC partnerships to de-risk clinical trials
            
February 17, 12 PM EST:
Repurposing drugs for new indications: benefits and challenges
            
February 23, 2 PM EST:
Flattening the 'valley of death:' New tools in the hunt for better preclinical 
R&D
            View All Upcoming Webinars                                         
IN CASE YOU MISSED IT        
   - Dan O’Day’s $5B deal with Galapagos implodes as PhIII trials collapse​   
Endpoints News
   - AbbVie taps Jennifer Doudna startup for licensing deal worth up to $300M 
for 2 'off-the-shelf' CRISPR-edited CAR-Ts   
Endpoints News
   - Updated: FDA panel admonishes Merck with a gentle — and rare — slapdown 
for rushing its pitch on an accelerated OK for adjuvant Keytruda in TNBC   
Endpoints News
   - With a roster of gene therapy vets, Forbion makes a bet on 'relatively 
empty space' of vectorized antibodies   
Endpoints News      
      - 'Industrializing the production of cells': Another iPSC player joins 
the quest for off-the-shelf cell therapies      
Endpoints News
      - With 'rapid' progress of pediatric brain cancer treatment, Day One sees 
broad excitement in new crossover round      
Endpoints News
      - On the hunt for a better antibody, BigHat Biosciences debuts with $19M 
Series A to scale its 'wet lab' AI platform      
Endpoints News

   - Eli Casdin and Icahn protégé find a home for their $450M SPAC, merging 
with Sema4   
Endpoints News
   - A year after FTC nixed Illumina buyout, Softbank bets $900M on PacBio's 
new vision   
Endpoints News
   - Eli Lilly racks up EUA for antibody cocktail — but the bigger challenge is 
still ahead   
Endpoints News
   - With Libtayo's second approval, Regeneron digs deeper into PD-1 
dermato-oncology niche   
Endpoints News
   - That cat Zoom filter is almost impossible to find. Here's why   
CNN
                              It's 40 degrees warmer in my fridge than the air 
outside — but the vaccine progress feels like spring to me. We picked up 
takeout at our favorite restaurant in town and the manager was beaming about 
receiving his first vaccine dose. My brother works in Kansas state government 
and he's got his first appointment. My Dad has his first Moderna shot, my 
stepdad got the Pfizer/BioNTech. Thank you, biopharma.            Early Edition 
edited by Amber Tong and Arsalan Arif
Email replies are monitored. Send us a tip: earlyedition@xxxxxxxxxxxxxxxxx      
                  Subscriptions/support help@xxxxxxxxxxxxxxxxx
Advertising/partnerships Mike Peck  mike@xxxxxxxxxxxxxxxxx
Work at Endpoints? Arsalan Arif  aa@xxxxxxxxxxxxxxxxx

Endpoints News 2029 Becker Dr; Lawrence, Kansas 66047              Tweet        
Share        Forward              Unsubscribe          |

 

Other related posts:

  • » [uupretirees] AstraZeneca scraps a lineup of drugs in pipeline cleanup; Takeda, 5AM back a Fred Hutch spinoff with grand ambitions - hils .